A Reduced Dose Whole Virion Aluminum Adjuvanted Seasonal Influenza Vaccine Is Immunogenic, Safe, and Well Tolerated in Pediatric Patients
Background: Data suggest that pediatric patients might react differently to influenza vaccination, both in terms of immunity and side effects. We have recently shown that using a whole virion vaccine with aluminum phosphate adjuvants, reduced dose vaccines containing 6 µg of viral hemagglutinin (HA)...
Main Authors: | Zoltan Vajo, Gergely Balaton, Peter Vajo, Peter Torzsa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/3/500 |
Similar Items
-
Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China versus a comparator influenza vaccine: a phase IV randomized study
by: Yuemei Hu, et al.
Published: (2019-05-01) -
Immunogenicity and safety of two quadrivalent influenza vaccines in healthy adult and elderly participants in India - A phase III, active-controlled, randomized clinical study
by: Indraneel Basu, et al.
Published: (2022-01-01) -
Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine in children and adolescents 6 months through 17 years of age in India
by: Nijalingappa K. Kalappanavar, et al.
Published: (2022-11-01) -
Understanding immunity differences induced by whole cell and acellular pertussis vaccines in a paediatric population
by: Martins Valente Pinto, AM
Published: (2021) -
Evaluation of Vaccine Immunogenicity—Correlates to Real-World Protection: Influenza
by: Csaba Laszlofy, et al.
Published: (2024-03-01)